title: Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind trial.
authors.forename: W W
authors.initials: WW
authors.lastname: Fleischhacker
authors.forename: C
authors.initials: C
authors.lastname: Barnas
authors.forename: C H
authors.initials: CH
authors.lastname: Stuppäck
authors.forename: B
authors.initials: B
authors.lastname: Unterweger
authors.forename: C
authors.initials: C
authors.lastname: Miller
authors.forename: H
authors.initials: H
authors.lastname: Hinterhuber
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003988:Dibenzothiepins / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011897:Random Allocation; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D003988:Dibenzothiepins; D006220:Haloperidol; C022172:zotepine